Obesity and Cardiovascular Disease. Risk Factor, Paradox, and Impact of Weight Loss

Journal of the American College of Cardiology

Volumn 53, Issue 21, 2009, Pages 1925-1932

  Lavie, Carl J ^a   Milani, Richard V ^a   Ventura, Hector O ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

cardiovascular disease; obesity; weight loss

Indexed keywords

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; STROKE; VEIN DISEASE; WEIGHT REDUCTION;

CARDIOVASCULAR DISEASES; HUMANS; OBESITY; PREVALENCE; RISK FACTORS; UNITED STATES; WEIGHT LOSS;

EID: 65549109680     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.068     Document Type: Review

References (87)

1. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 113 (2006) 898-918
2. Klein S., Burke L.E., Bray G.A., et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 110 (2004) 2952-2967
3. Litwin S.E. Which measures of obesity best predict cardiovascular risk?. J Am Coll Cardiol 52 (2008) 616-619
4. Pischon T., Boeing H., Hoffmann K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 359 (2008) 2105-2120
5. Flegal J.N., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
6. Lavie C.J., and Milani R.V. Obesity and cardiovascular disease: the Hippocrates paradox?. J Am Coll Cardiol 42 (2003) 677-679
7. Manson J.E., and Bassuk S.S. Obesity in the United States: a fresh look at its high toll. JAMA 289 (2003) 229-230
8. Sturm R., and Well K.B. Does obesity contribute as much to morbidity as poverty or smoking?. Public Health 115 (2001) 229-235
9. Ford E.S., and Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 50 (2007) 2128-2132
10. Martin S.S., Qasim A., and Reilly M.P. Leptin resistance. J Am Coll Cardiol 52 (2008) 1201-1210
11. Lavie C.J., Milani R.V., and Ventura H.O. Untangling the heavy cardiovascular burden of obesity. Nat Clin Pract Cardiovasc Med 5 (2008) 428-429
12. Enriori P.J., Evans A.E., Sinnayah P., and Crowley M.A. Leptin resistance and obesity. Obesity 14 Suppl 5 (2006) 254S-258S
13. Romero-Corral A., Sierra-Johnson J., Lopez-Jimenez F., et al. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med 5 (2008) 418-425
14. Alpert M.A. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321 (2001) 225-236
15. Messerli F.H., Ventura H.O., Reisin E., et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 66 (1982) 55-60
16. Messerli F.H., Nunez B.D., Ventura H.O., and Snyder D.W. Overweight and sudden death: increased ventricular ectopy in cardiomyopathy of obesity. Arch Intern Med 147 (1987) 1725-1728
17. Messerli F.H. Cardiomyopathy of obesity: a not-so-Victorian disease. N Engl J Med 314 (1986) 378-380
18. Lavie C.J., Milani R.V., Ventura H.O., Cardenas G.A., Mehra M.R., and Messerli F.H. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 100 (2007) 1460-1464
19. Lavie C.J., Amodeo C., Ventura H.O., and Messerli F.H. Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity. Chest 92 (1987) 1042-1046
20. Wang T.J., Parise H., Levy D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004) 2471-2477
21. Chakko S., Mayor M., Allison M.D., Kessler K.M., Materson B.J., and Myerburg R.J. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity. Am J Cardiol 68 (1991) 95-98
22. Garavaglia G.E., Messerli F.H., Nunez B.D., Schmieder R.E., and Grossman E. Myocardial contractility and left ventricular function in obese patients with essential hypertension. Am J Cardiol 62 (1988) 594-597
23. Alpert M.A., Terry B.E., Mulekar M., et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80 (1997) 736-740
24. The Horton Quote. www.dictionaryquotes.com/authorquotations/101/Doug_Horton.php Accessed April 1, 2008
25. Uretsky S., Messerli F.H., Bangalore S., et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120 (2007) 863-870
26. Wassertheil-Smoller S., Fann C., Allman R.M., et al., SHEP Cooperative Research Group. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. Arch Intern Med 160 (2000) 494-500
27. Stamler R., Ford C.E., and Stamler J. Why do lean hypertensive patients have higher mortality rates than other hypertensive patients?. Findings of the hypertension detection and follow-up program. Hypertension 17 (1991) 553-564
28. Tuomilehto J. Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly. Am J Med 90 (1991) 34S-41S
29. Lavie C.J., Milani R.V., and Ventura H.O. Obesity, heart disease, and favorable prognosis-truth or paradox?. Am J Med 120 (2007) 825-826
30. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
31. Horwich T.B., Fonarow G.C., Hamilton M.A., et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001) 789-795
32. Lavie C.J., Osman A.F., Milani R.V., and Mehra M.R. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003) 891-894
33. Lavie C.J., Milani R.V., Artham S.M., et al. Does body composition impact survival in patients with advanced heart failure (abstr). Circulation 116 (2007) II360
34. Oreopoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156 (2008) 13-22
35. Fonarow G.C., Srikanthan P., Costanzo M.R., et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry. Am Heart J 153 (2007) 74-81
36. Lavie C.J., Mehra M.R., and Milani R.V. Obesity and heart failure prognosis: paradox or reverse epidemiology. Eur Heart J 26 (2005) 5-7
37. Kalantar-Zadeh K., Block G., Horwich T., and Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 1439-1444
38. Anker S., Negassa A., Coats A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
39. Mohamed-Ali V., Goodrick S., Bulmer K., et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277 (1999) E971-E975
40. Mehra M.R., Uber P.A., Parh M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 (2004) 1590-1595
41. Rauchhaus M., Coats A.J.S., and Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 356 (2000) 930-933
42. Hubert H.B., Feinleib M., McNamara P.M., and Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983) 968-977
43. Lavie C.J., and Milani R.V. Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes. J Cardiopulm Rehabil 25 (2005) 59-66
44. Gelber R.P., Gaziano J.M., Oraw E.J., et al. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52 (2008) 605-615
45. Zhang C., Rexrode K.M., and van Dam R.M. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117 (2008) 1658-1667
46. Madala M.C., Franklin B.A., Chen A.Y., et al. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 52 (2008) 979-985
47. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
48. Lavie C.J., Milani R.V., Artham S.M., et al. The obesity paradox, weight loss, and coronary disease. Am J Med (2009) In press
49. McAuley P., Myers J., Abella J., and Froelicher V. Body mass, fitness and survival in veteran patients: another obesity paradox?. Am J Med 120 (2007) 518-524
50. Galal W., van Gestel Y., Hoeks S.E., et al. The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease. Chest 134 (2009) 925-930
51. Lavie C.J., Ventura H.O., and Milani R.V. The "obesity paradox"-is smoking/lung disease the explanation?. Chest 134 (2009) 896-898
52. Wanahita N., Messerli F.H., Bangalore S., et al. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 155 (2008) 310-315
53. Kurth T., Gaziano J.M., Berger K., et al. Body mass index and the risk of stroke in men. Arch Intern Med 162 (2002) 2557-2562
54. Chadwick J., and Mann W.N. Medical Works of Hippocrates (1950), Blackwell Scientific, Boston, MA 154
55. Kannel W.B., Plehn J.F., and Cupples L.A. Cardiac failure and sudden death in the Framingham Study. Am Heart J 115 (1988) 869-875
56. el-Gamal A., Gallagher D., Nawras A., et al. Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol 75 (1995) 956-959
57. Mshui M.E., Saikawa T., Ito K., Hara M., and Sakata T. QT interval and QT dispersion before and after diet therapy in patients with simple obesity. Proc Soc Exp Biol Med 220 (1999) 133-138
58. Rasmussen L.H., and Andersen T. The relationship between QTc changes and nutrition during weight loss after gastroplasty. Acta Med Scand 217 (1985) 271-275
59. Lalani A.P., Kanna B., John J., Ferrick K.J., Huber M.S., and Shapiro L.E. Abnormal signal-averaged electrocardiogram (SAECG) in obesity. Obes Res 8 (2000) 20-28
60. Trollo Jr. P.J., and Rogers R.M. Obstructive sleep apnea. N Engl J Med 334 (1996) 99-104
61. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 28 (2002) 2462-2464
62. Partinen M., Jamieson A., and Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 94 (1988) 1200-1204
63. Sugerman H.J., Suggerman E.I., Wolfe L., Kellum Jr. J.M., Schweitzer M.A., and DeMaria E.J. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg 234 (2001) 41-46
64. Tsai A.W., Cushman M., Rosamond W.D., Heckbert S.R., Polak J.F., and Folsom A.R. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 162 (2002) 1182-1189
65. Goldhaber S.Z., Grodstein F., Stampfer M.J., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 277 (1997) 642-645
66. Fonarow G.C., Horwich T.B., Hamilton M.A., et al. Obesity, weight reduction and survival in heart failure: reply. J Am Coll Cardiol 39 (2002) 1563-1564
67. Allison D.B., Zannolli R., Faith M.S., et al. Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies. Int J Obes Relat Metab Disord 23 (1999) 603-611
68. Sierra-Johnson J., Romero-Corral A., Somers V.K., et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur Cardiovasc Prev Rehabil 15 (2008) 336-340
69. Sorensen T.I. Weight loss causes increased mortality: pros. Obes Rev 4 (2003) 3-7
70. Connolly H.M., Crary J.L., McGroom M.D., et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337 (1997) 581-588
71. Albenhaim L., Moride Y., Brenot F., et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International primary pulmonary hypertension study group. N Engl J Med 335 (1996) 609-616
72. Zannad F., Gille B., Grentzinger A., et al. Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction. Am Heart J 144 (2002) 508-515
73. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
74. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
75. Milani R.V., and Lavie C.J. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol 92 (2003) 50-54
76. Lavie C.J., and Milani R.V. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 79 (1997) 397-401
77. Lavie C.J., Morshedi-Meibodi A., and Milani R.V. Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients. J Cardiometab Syndr 3 (2008) 136-140
78. Eilat-Adar S., Eldar M., and Goldbourt U. Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol 161 (2005) 352-358
79. MacMahon S., Collins G., Rautaharju P., et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial. Am J Cardiol 63 (1989) 202-210
80. Flum D.R., and Dellinger E.P. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 199 (2004) 543-551
81. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
82. Sjöström L., Narbro K., Sjöström C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
83. Christou N.V., Sampalis J.S., Liberman M., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 (2004) 416-424
84. Batsis J.A., Romero-Corral A., and Collazo-Claveli M.L. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc 83 (2008) 897-906
85. Batsis J.A., Sarr M.G., Collazo-Clavell M.L., et al. Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol 102 (2008) 930-937
86. Sjöström C.D., Peltonen M., Wedel H., and Sjöström L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 36 (2000) 20-25
87. Ramani G.V., McCloskey C., Ramanathan R.C., and Mathier M.A. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol 31 (2008) 516-520